Process for preparing 6-o-alkenyl-substituted erythromycin derivatives
A technology of erythromycin derivatives, 6-O-, applied in the field of preparation of 6-O-substituted erythromycin derivatives
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0123] Preparation of 6-O-allyl-2',4"-O-di-trimethyl from allyl tert-butyl carbonate
[0124] Silylerythromycin A-9-(O-isopropoxy-cyclohexyl ketal) oxime
[0125] (Compound (III), Reaction Scheme 1) Step (1): 2', 4 "-two-trimethylsilyl erythromycin A-9-(O-isopropoxycyclohexyl ketal) oxime preparation
[0126] The above compound was prepared according to the method described in US Patent 4,990,602. Step (2): 6-O-allyl-2', 4"-O-bis-trimethylsilyl erythromycin A-9-(O-isopropoxycyclohexyl ketal) oxime preparation
[0127] 2', 4"-O-bis(trimethylsilyl)erythromycin A 9-(O-isopropoxycyclohexyl ketal) oxime) (30.0g, 29.0mmol, 1 equivalent), ene Propyl tert-butyl carbonate (6.65 g, 1.45 equiv), palladium acetate (33 mg, 0.005 equiv), triphenylphosphine (330 mg, 0.043 equiv) and 150 mL of THF were added to a suitable reaction vessel. The reaction mixture was pumped After being vacuumed and purged several times with nitrogen, it was heated to reflux for 19 hour...
Embodiment 2
[0131] Preparation of 6-O-allyl 2',4"-di-O- from allyl isopropyl carbonate
[0132] Trimethylsilyl-erythromycin A 9-(O-isopropoxycyclohexyl ketal) oxime
[0133] The title compound was prepared according to the method of Example 1 step (2) with a crude product yield of 80%, except that 1.8 molar equivalents of allyl isopropyl carbonate prepared in Reference Example 4 were used instead of allyl tertiary Butyl carbonate.
Embodiment 3
[0135] 6-O-[3-(3-quinolinyl)-2-propen-1-yl]-2',4"-di-O-trimethylsilyl-
[0136] Preparation of erythromycin A 9-(O-isopropoxycyclohexyl ketal) oxime
[0137] The title compound was prepared according to the method of Example 1 step (2) with a crude product yield of 92%, except that 1.2 molar equivalents of 1-(3-quinolyl)-2-propene prepared in Reference Example 5 were used -1-ol tert-butyl carbonate instead of allyl tert-butyl carbonate.
[0138] 1 H NMR (400MHz, CDCl 3 ): 9.06 (clear doublet, 1H), 8.30 (clear doublet, 1H), 8.04 (clear doublet, 1H), 7.78 (clear doublet, 1H), 7.61 (clear doublet, doublet peak, 1H), 7.48 (obvious double doublet, 1H), 6.62-6.50 (m, 2H), 5.19 (clear doublet, 1H), 4.80 (obvious doublet, 1H), 4.56-4.39 (m, 2H), 4.28-4.24(m, 2H), 4.13-4.01(m, 2H), 3.83-3.65(m, 5H), 3.30-3.15(m, 6H), 2.91-2.82(m, 1H) , 2.75-2.70(m, 1H), 2.65-2.51(m, 1H), 2.35-2.20(m, 7H), 2.10-1.02(m, 50H), 0.89-0.82(m, 4H), 0.16(s, 9H), 0.12(s, 9H). 13 CNMR (100MHz, CDCl...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com